RHO and thyroid gland carcinoma: The downstream signaling pathways associated with CD97 have not yet been fully elucidated, there is evidence that these receptors signal through Gα12/13, resulting in increased RHO-GTP and activation of extracellular signal-regulated kinase (ERK) in prostate and thyroid cancers [60,61].